Maria Van Kerkhove, WHO’s COVID-19 technical lead, said on Saturday that from the limited number of reporting countries, COVID-19 hospitalizations and ICU admissions have increased by 35 percent in the past month.
कोरोना के नए वेरिएंट जेएन1 ने बधाई चिंता, नई लहर से लोगों में ख़ौफ़, दुनियाभर में बढ़ रहे केस
Cases of the new Omicron sub-variant JN1 of corona virus are increasing across the world including India. Therefore, there is a fear among many people of a possible Covid wave in early 2024 which could once again derail life.
743 new cases of Covid-19 were registered in India on Saturday. According to the Union Health Ministry, with this the total number of active patients in the country increased to 3,997. A total of 162 cases of JN1 have been reported so far in India. In which maximum 83 cases have been registered in Kerala.
With this, the total number of corona virus cases in India since January 2020 has increased to 4,50,12,484. Whereas after the death of 7 people in the last 24 hours, the total death toll has increased to 5,33,358.
Globally, cases of JN1 have been reported from the US, some European countries, Singapore and China. “From a limited number of reporting countries, COVID-19 hospitalizations and ICU admissions increased by 35 percent over the past month,” Maria Van Kerkhove, WHO’s COVID-19 technical lead, said on Saturday. Is.
He further said that cases of CARS-CoV-2, influenza and other respiratory diseases continue to increase. One should take measures to protect oneself from infection. Maria Van Kerkhove said JN1 continues to grow in recognition. But what matters is that COVID-19 cases are increasing in all countries.
He posted from his X account, “You can protect yourself from infection and serious illness.” Mask, ventilate, test, treat, boost vaccine doses every 6-12 months depending on risk.
According to Dr. Soumya Swaminathan, former Director General of the Indian Council of Medical Research (ICMR), the JN1 COVID-19 variant is more infectious than other variants. The World Health Organization (WHO) has classified JN1 as a separate variant due to its rapidly increasing spread. But said it poses little global public health risk.
According to Dr Ishwar Gilada, consultant at the Infectious Diseases Unison Medicare and Research Center in Mumbai, unless JN1 becomes a ‘matter of concern’. Till then the common man should not be troubled by this.
He said that India has managed the Covid-19 pandemic better than many powerful countries. The maximum number of vaccinations against Covid-19 has been done in India. In which 75 percent of the population has been fully vaccinated and 35 percent of the population has received a booster (third dose).
The third wave, driven by the Omicron variant primarily along with the BA.2 sub-variant, infected most of the population with minimal morbidity and mortality.
He further said that in fact the BA.2 was a savior for India from the transition to BA.2, BA.4 and BA.5 as well as the BA.2’s descendants like BA.2.86 (Pirola). Now we are better prepared than ever. Not only this, India provides assistance with preparations, medicines and vaccines to more than 50 countries in Africa and elsewhere.
However, JN1 was identified in Luxembourg in August 2023. It is currently present in more than 40 countries and has not infected or caused large numbers of deaths. Dr. Gilada said that the presence of JN1 has not increased the demand for oxygen, beds, ICU beds or ventilators. Experts urge senior citizens and people with co-morbidities, as well as people visiting crowded places, to wear masks.
“Some patients are at increased risk of serious outcomes and increased mortality from Covid,” said Dr Vikas Chopra, Senior Consultant Interventional Cardiologist, Primus Super Specialty Hospital.
Common comorbidities associated with higher mortality risk include cardiovascular disease such as high blood pressure, coronary artery disease, chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), diabetes, obesity, and a weakened immune system.
Follow Us on… 
